Company News
Mahamaya Lifesciences FY26 Revenue Up 24.5%
Mahamaya Lifesciences reported FY2025-26 revenue of ₹328.87 crore, up 24.5% YoY, with PAT increasing 29% to ₹16.52 crore.
The company is deploying IPO proceeds primarily towards its phased Dahej techn
